Industry News
Flow Neuroscience Brings First FDA-Approved At-Home Brain Stimulation for Depression to US Market
The Swedish company's FL-100 headset, cleared via the FDA's most stringent PMA pathway, launches in the US in Q2 2026 after a 174-person Nature Medicine trial. A second device, Neurolief's ProlivRx, was approved weeks later.